CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 12 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,596,000 | +5.8% | 1,629,000 | +2.3% | 0.04% | +2.9% |
| Q1 2021 | $1,509,000 | +11.4% | 1,592,000 | +8.2% | 0.04% | 0.0% |
| Q4 2020 | $1,354,000 | -1.0% | 1,472,000 | 0.0% | 0.04% | -14.6% |
| Q3 2020 | $1,368,000 | -43.0% | 1,472,000 | -44.7% | 0.04% | -46.1% |
| Q2 2020 | $2,398,000 | -27.5% | 2,664,000 | -26.7% | 0.08% | -35.0% |
| Q1 2020 | $3,309,000 | +2.3% | 3,636,000 | 0.0% | 0.12% | +27.2% |
| Q4 2019 | $3,236,000 | +2.2% | 3,636,000 | 0.0% | 0.09% | -5.2% |
| Q3 2019 | $3,165,000 | -2.1% | 3,636,000 | 0.0% | 0.10% | -3.0% |
| Q2 2019 | $3,234,000 | -4.1% | 3,636,000 | -0.1% | 0.10% | -7.4% |
| Q1 2019 | $3,374,000 | +9.5% | 3,641,000 | +0.1% | 0.11% | -4.4% |
| Q4 2018 | $3,080,000 | +163.2% | 3,639,000 | +191.1% | 0.11% | +253.1% |
| Q3 2018 | $1,170,000 | -13.3% | 1,250,000 | 0.0% | 0.03% | -17.9% |
| Q2 2018 | $1,349,000 | +131.0% | 1,250,000 | +150.0% | 0.04% | +95.0% |
| Q1 2018 | $584,000 | -14.0% | 500,000 | 0.0% | 0.02% | -13.0% |
| Q4 2017 | $679,000 | -12.7% | 500,000 | 0.0% | 0.02% | -17.9% |
| Q3 2017 | $778,000 | -8.1% | 500,000 | 0.0% | 0.03% | -12.5% |
| Q2 2017 | $847,000 | +31.3% | 500,000 | 0.0% | 0.03% | +28.0% |
| Q1 2017 | $645,000 | +25.0% | 500,000 | 0.0% | 0.02% | +31.6% |
| Q4 2016 | $516,000 | +7.3% | 500,000 | -0.4% | 0.02% | +11.8% |
| Q3 2016 | $481,000 | +14.5% | 502,000 | -14.3% | 0.02% | +13.3% |
| Q2 2016 | $420,000 | +4.7% | 586,000 | 0.0% | 0.02% | +15.4% |
| Q1 2016 | $401,000 | -7.6% | 586,000 | +16.3% | 0.01% | -7.1% |
| Q4 2015 | $434,000 | -55.3% | 504,000 | -13.6% | 0.01% | -51.7% |
| Q3 2015 | $971,000 | – | 583,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|